replication defective adenovirus Latest Research Papers

A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy

PLoS ONE ◽

10.1371/journal.pone.0192882 ◽

2018 ◽

Vol 13 (2) ◽

pp. e0192882 ◽

Cited By ~ 5

Author(s):

Faizule Hassan ◽

Sarah L. Lossie ◽

Ellen P. Kasik ◽

Audrey M. Channon ◽

Shuisong Ni ◽

...

Keyword(s):

Mouse Model ◽

Cancer Treatment ◽

Binding Site ◽

Adenovirus Serotype ◽

Model Study ◽

Serotype 5 ◽

Replication Defective Adenovirus

Get full-text (via PubEx)

Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer

Cancer Gene Therapy ◽

10.1038/cgt.2016.41 ◽

2016 ◽

Vol 23 (10) ◽

pp. 355-364 ◽

Cited By ~ 6

Author(s):

C M Wong ◽

L A Nash ◽

J Del Papa ◽

K L Poulin ◽

T Falls ◽

...

Keyword(s):

Mouse Model ◽

Adenovirus Vector ◽

Therapeutic Benefit ◽

Immunocompetent Mouse ◽

Replication Defective Adenovirus

Get full-text (via PubEx)

Vaccine Design: Replication-Defective Adenovirus Vectors

Vaccine Design - Methods in Molecular Biology ◽

10.1007/978-1-4939-3389-1_23 ◽

2016 ◽

pp. 329-349 ◽

Cited By ~ 3

Author(s):

Xiangyang Zhou ◽

Zhiquan Xiang ◽

Hildegund C. J. Ertl

Keyword(s):

Vaccine Design ◽

Adenovirus Vectors ◽

Replication Defective Adenovirus

Get full-text (via PubEx)

Enhanced recombinant human blood coagulation factor VIII expression in the milk of goats using replication-defective adenovirus

AFRICAN JOURNAL OF BIOTECHNOLOGY ◽

10.5897/ajb2015.14492 ◽

2015 ◽

Vol 14 (17) ◽

pp. 1504-1510

Author(s):

Han Zengsheng ◽

Wang Lin ◽

Li Kun ◽

Li Jian ◽

Zhao Hongwei ◽

...

Keyword(s):

Factor Viii ◽

Blood Coagulation ◽

Human Blood ◽

Coagulation Factor ◽

Coagulation Factor Viii ◽

Blood Coagulation Factor Viii ◽

Human Blood Coagulation ◽

Replication Defective Adenovirus

Get full-text (via PubEx)

Heterologous Prime-Boost Schedules of Replication-Defective Adenovirus Serotype 26 and Modified Vaccinia Virus Ankara Vector Vaccines Expressing Ebola Virus Glycoprotein Are Immunogenic and Well Tolerated in Healthy Adults

Open Forum Infectious Diseases ◽

10.1093/ofid/ofv131.97 ◽

2015 ◽

Vol 2 (suppl_1) ◽

Author(s):

Iain Milligan ◽

Malick Gibani ◽

Danielle Campbell ◽

Elizabeth Clutterbuck ◽

Richard Sewell ◽

...

Keyword(s):

Vaccinia Virus ◽

Ebola Virus ◽

Healthy Adults ◽

Adenovirus Serotype ◽

Virus Glycoprotein ◽

Modified Vaccinia Virus Ankara ◽

Replication Defective Adenovirus

Get full-text (via PubEx)

Porcine granulocyte-colony stimulating factor (G-CSF) delivered via replication-defective adenovirus induces a sustained increase in circulating peripheral blood neutrophils

Biologicals ◽

10.1016/j.biologicals.2013.07.001 ◽

2013 ◽

Vol 41 (6) ◽

pp. 368-376 ◽

Cited By ~ 9

Author(s):

Crystal L. Loving ◽

Marcus E. Kehrli ◽

Susan L. Brockmeier ◽

Darrell O. Bayles ◽

David D. Michael ◽

...

Keyword(s):

Peripheral Blood ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Blood Neutrophils ◽

Stimulating Factor ◽

Replication Defective Adenovirus ◽

Sustained Increase ◽

Factor G

Get full-text (via PubEx)

Construction and identification of recombinant replication-defective adenovirus vector Αd/CMV/V5-DEST-TNFα-scFv

World Chinese Journal of Digestology ◽

10.11569/wcjd.v21.i22.2192 ◽

2013 ◽

Vol 21 (22) ◽

pp. 2192

Author(s):

Meng Zhuo

Keyword(s):

Adenovirus Vector ◽

Replication Defective Adenovirus

Get full-text (via PubEx)

Short Communication: Enhancement of Immunogenicity of Replication-Defective Adenovirus-Based Human Immunodeficiency Virus Vaccines in Rhesus Monkeys

AIDS Research and Human Retroviruses ◽

10.1089/aid.2010.0210 ◽

2011 ◽

Vol 27 (6) ◽

pp. 681-686 ◽

Cited By ~ 2

Author(s):

Caijun Sun ◽

Yinfeng Zhang ◽

Yichu Liu ◽

Maochao Zhang ◽

Ling Chen

Keyword(s):

Human Immunodeficiency Virus ◽

Rhesus Monkeys ◽

Short Communication ◽

Immunodeficiency Virus ◽

Replication Defective Adenovirus

Get full-text (via PubEx)

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)

PLoS ONE ◽

10.1371/journal.pone.0013579 ◽

2010 ◽

Vol 5 (10) ◽

pp. e13579 ◽

Cited By ~ 41

Author(s):

Laurence Peiperl ◽

Cecilia Morgan ◽

Zoe Moodie ◽

Hongli Li ◽

Nina Russell ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Adenovirus Type ◽

Hiv Vaccine ◽

Adenovirus Type 5 ◽

Replication Defective Adenovirus

Get full-text (via PubEx)

CD8+T Cell Responses following Replication-Defective Adenovirus Serotype 5 Immunization Are Dependent on CD11c+Dendritic Cells but Show Redundancy in Their Requirement of TLR and Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling

The Journal of Immunology ◽

10.4049/jimmunol.1000338 ◽

2010 ◽

Vol 185 (3) ◽

pp. 1513-1521 ◽

Cited By ~ 53

Author(s):

Ross W. B. Lindsay ◽

Patricia A. Darrah ◽

Kylie M. Quinn ◽

Ulrike Wille-Reece ◽

Lisa M. Mattei ◽

...

Keyword(s):

Dendritic Cells ◽

T Cell ◽

T Cell Responses ◽

Nucleotide Binding ◽

Cd8 T Cell ◽

Adenovirus Serotype ◽

Cell Responses ◽

Serotype 5 ◽

Replication Defective Adenovirus ◽

Oligomerization Domain

Get full-text (via PubEx)

replication defective adenovirus
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy

Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer

Vaccine Design: Replication-Defective Adenovirus Vectors

Enhanced recombinant human blood coagulation factor VIII expression in the milk of goats using replication-defective adenovirus

Heterologous Prime-Boost Schedules of Replication-Defective Adenovirus Serotype 26 and Modified Vaccinia Virus Ankara Vector Vaccines Expressing Ebola Virus Glycoprotein Are Immunogenic and Well Tolerated in Healthy Adults

Porcine granulocyte-colony stimulating factor (G-CSF) delivered via replication-defective adenovirus induces a sustained increase in circulating peripheral blood neutrophils

Construction and identification of recombinant replication-defective adenovirus vector Αd/CMV/V5-DEST-TNFα-scFv

Short Communication: Enhancement of Immunogenicity of Replication-Defective Adenovirus-Based Human Immunodeficiency Virus Vaccines in Rhesus Monkeys

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)

CD8+T Cell Responses following Replication-Defective Adenovirus Serotype 5 Immunization Are Dependent on CD11c+Dendritic Cells but Show Redundancy in Their Requirement of TLR and Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling

Export Citation Format

replication defective adenovirusRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy

Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer

Vaccine Design: Replication-Defective Adenovirus Vectors

Enhanced recombinant human blood coagulation factor VIII expression in the milk of goats using replication-defective adenovirus

Heterologous Prime-Boost Schedules of Replication-Defective Adenovirus Serotype 26 and Modified Vaccinia Virus Ankara Vector Vaccines Expressing Ebola Virus Glycoprotein Are Immunogenic and Well Tolerated in Healthy Adults

Porcine granulocyte-colony stimulating factor (G-CSF) delivered via replication-defective adenovirus induces a sustained increase in circulating peripheral blood neutrophils

Construction and identification of recombinant replication-defective adenovirus vector Αd/CMV/V5-DEST-TNFα-scFv

Short Communication: Enhancement of Immunogenicity of Replication-Defective Adenovirus-Based Human Immunodeficiency Virus Vaccines in Rhesus Monkeys

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)

CD8+T Cell Responses following Replication-Defective Adenovirus Serotype 5 Immunization Are Dependent on CD11c+Dendritic Cells but Show Redundancy in Their Requirement of TLR and Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling

replication defective adenovirus
Recently Published Documents